文献速递肝胆胰外科

腹腔镜与开腹肝切除治疗混合型肝细胞-胆管癌的围术期与肿瘤学结局:倾向性评分匹配分析

Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis.
PubMed 文献 · Surg Endosc · 2022-09-08

腹腔镜组术后住院更短(6.61 vs. 8.26天,p<0.001),并发症发生率与切缘阴性率无显著差异,术后第1、3天AST、ALT及炎症指标更低,总生存与无复发生存相当。

要点

  • 腹腔镜肝切除治疗cHCC-CC术后住院更短(6.61 vs. 8.26天,p<0.001)。
  • 两组并发症发生率(p=0.409)与切缘阴性率(p=1.000)无显著差异。
  • 腹腔镜组总生存(p=0.700)与无复发生存(p=0.780)与开腹组相当。

核心结论

  • 与开腹肝切除相比,腹腔镜肝切除治疗cHCC-CC可减轻肝功能损伤和炎症反应、加快康复,且肿瘤学结局相当。
  • 腹腔镜肝切除可作为经过选择的cHCC-CC患者安全有效的治疗方式,尤其适用于肿瘤较小、位置合适的患者。

研究设计与样本

  • 采用1:2倾向性评分匹配(PSM)分析比较腹腔镜与开腹组的围术期和肿瘤学结局,匹配后纳入腹腔镜34例与开腹68例。
  • 总生存(OS)和无复发生存(RFS)采用log-rank检验及敏感性分析评估。

主要发现

  • 匹配后腹腔镜组术后住院时间短于开腹组(6.61 vs. 8.26天;p<0.001)。
  • 两组术后并发症发生率(p=0.409)和切缘阴性率(p=1.000)无显著差异。
  • 腹腔镜组术后第1天和第3天AST、ALT及炎症指标显著低于开腹组。
  • 两组OS(p=0.700)和RFS(p=0.780)相当,敏感性分析结果相似。

临床怎么用

  • 对经过选择的cHCC-CC患者,尤其肿瘤较小、位置合适者,可考虑腹腔镜肝切除以加快术后恢复。
  • 腹腔镜肝切除在cHCC-CC中未显示肿瘤学结局劣于开腹手术,但仍需结合患者选择和术者经验。

局限性

  • 单中心回顾性研究,匹配后腹腔镜组样本量较小(34例)。
  • 原文未报告长期随访时长及选择偏倚控制等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver resection (LLR) has now been established as a safe and minimally invasive technique that is deemed feasible for treating hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). However, the role of LLR in treating combined hepatocellular-cholangiocarcinoma (cHCC-CC) patients has been rarely reported. This study aimed to assess the efficacy of LLR when compared with open liver resection (OLR) procedure for patients with cHCC-CC. METHODS: A total of 229 cHCC-CC patients who underwent hepatic resection (34 LLR and 195 OLR patients) from January 2014 to December 2018 in Zhongshan Hospital, Fudan University were enrolled and underwent a 1:2 propensity score matching (PSM) analysis between the LLR and OLR groups to compare perioperative and oncologic outcomes. Overall survival (OS) and recurrence-free survival (RFS) parameters were assessed by the log-rank test and the sensitivity analysis. RESULTS: A total of 34 LLR and 68 OLR patients were included after PSM analysis. The LLR group displayed a shorter postoperative hospital stay (6.61 vs. 8.26 days; p value < 0.001) when compared with the OLR group. No significant differences were observed in the postoperative complications' incidence or a negative surgical margin rate between the two groups (p value = 0.409 and p value = 1.000, respectively). The aspartate aminotransferase (AST), alanine aminotransferase (ALT), and inflammatory indicators in the LLR group were significantly lower than those in the OLR group on the first and third postoperative days. Additionally, OS and RFS were comparable in both the LLR and OLR groups (p value = 0.700 and p value = 0.780, respectively), and similar results were obtained by conducting a sensitivity analysis. CONCLUSION: LLR can impart less liver function damage, better inflammatory response attenuation contributing to a faster recovery, and parallel oncologic outcomes when compared with OLR. Therefore, LLR can be recommended as a safe and effective therapeutic modality for treating selected cHCC-CC patients, especially for those with small tumors in favorable location.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Song DJ, Zhu K, Tan JP, et al. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis. Surg Endosc. 2022. PMID: 36076103. doi:10.1007/s00464-022-09579-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。